Composite alginate and gelatin based bio-polymeric wafers containing silver sulfadiazine for wound healing

Boateng, Joshua; Burgos-Amador, Rocio; Okeke, O. P.; Pawar, Harshavardhan

doi:10.1016/j.ijbiomac.2015.04.048

Cited by 113 publications

(65 citation statements)

References 31 publications

(3 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…On the other hand, wafers have been employed as wound healing [16] and buccal [18] drug delivery systems. They can therefore be employed in the delivery of NIC, including composite systems combining two or more polymers [16,17] as demonstrated by Pawar and co-workers [18,19] who reported the use of composite polymeric wafers combining polyox with either carrageenan or sodium alginate in the development of wafers for controlled delivery of drugs to chronic wound sites [18,19].…”

Section: Introductionmentioning

confidence: 99%

Composite HPMC and sodium alginate based buccal formulations for nicotine replacement therapy

Okeke

Boateng

2016

International Journal of Biological Macromolecules

View full text Add to dashboard Cite

Smoking cessation is of current topical interest due to the significant negative health and economic impact in many countries. This study aimed to develop buccal films and wafers comprising HPMC and sodium alginate (SA) for potential use in nicotine replacement therapy via the buccal mucosa, as a cheap but effective alternative to currently used nicotine patch and chewing gum. The formulations were characterised using texture analyser (tensile and hardness, mucoadhesion), scanning electron microscopy, x-ray diffractometry, attenuated total reflection -Fourier transform infrared (ATR-FTIR), differential scanning calorimetry (DSC) and swelling capacity. Drug loaded films and wafers were characterised for content uniformity (HPLC) whilst the drug loaded wafers only were further characterised for in vitro drug dissolution. SA modified and improved the functional properties of HPMC at optimum ratio of HPMC: SA of 1.25 : 0.75. Generally, both films and wafers (blank and drug loaded) were amorphous in nature which impacted on swelling and mucoadhesive performance.HPMC-SA composite wafers showed a porous internal morphology with higher mucoadhesion, swelling index and drug loading capacity compared to the HPMC-SA composite films which were non-porous. The study demonstrates the potential use of composite HPMC-SA wafers in the buccal delivery nicotine.

show abstract

Section: Introductionmentioning

confidence: 99%

Composite HPMC and sodium alginate based buccal formulations for nicotine replacement therapy

Okeke

Boateng

2016

International Journal of Biological Macromolecules

View full text Add to dashboard Cite

show abstract

“…Cohesiveness determines the ability of the sample to resist the separation from the mucosal (wound) substrate due to the intermolecular forces (such as those from hydrogen bonding and van der Waals forces). It is determined through the distance travelled by sample before being detached 10,[20][21][22] .…”

Section: Introductionmentioning

confidence: 99%

Evaluation of in vitro wound adhesion characteristics of composite film and wafer based dressings using texture analysis and FTIR spectroscopy: a chemometrics factor analysis approach

Boateng

Pawar

2015

RSC Adv.

View full text Add to dashboard Cite

The adhesive properties of two dressing types, solvent cast films and freeze-dried wafers have been determined and compared using two analytical techniques, combined with chemometrics data analysis. Films and wafers were prepared from gels containing polyox (POL) combined with carrageenan (CAR) or sodium alginate (SA), glycerol (GLY) as plasticiser (films) with streptomycin and diclofenac as model drugs. The gels were dried in an oven at 40°C or freeze-dried to obtain films and wafers respectively. The adhesive performance of the films and wafers was assessed with 6.67% w/v gel using a texture analyser to measure the stickiness, work of adhesion and cohesiveness. The effect of viscosity of simulated wound fluid[(containing (2% w/w or 5% w/w bovine serum albumin)] and mucin solution (2% w/w) present on the gelatin surface on texture analyser profiles was investigated. Furthermore, the adhesive properties were estimated and evaluated using attenuated total reflectance Fourier transform infrared spectroscopy by monitoring the diffusion of mucin solution [2% w/w in phosphate buffered saline (PBS) pH 7.4] through the formulations. The diffusion data was analysed using target factor analysis (chemometrics approach) to establish proof of concept for predicting adhesion by measuring mucin interaction and its diffusion through films and wafers. There was a significant effect of simulated wound fluid, viscosity, plasticizer (for films) and drug loading on the adhesive performance of both films and wafers. POL-SA films showed higher mucoadhesive performance in the presence of viscous simulated wound fluid containing 5% bovine serum albumin. Wafers and plasticised films demonstrated high detachment force indicating strong interactions between the chains of the polymers (POL, SA and CAR) and the model wound surface (gelatin). ATR-FTIR spectroscopy showed that mucin diffused independently through the solvent and across the films and wafers. POL-CAR films generally showed slower diffusion of mucin when compared with POL-SA films whilst the opposite effect was observed for diffusion through POL-CAR wafers and POL-SA wafers. Generally, diffusion through wafers was faster than the corresponding films.

show abstract

“…Silver sulfadiazine (SSD)-impregnated hydrogel was prepared by polyvinyl alcohol (PV") and dextran blending. "oateng et al [115] formulated an ideal lyophilized wafer dressing composed of alginate and gelatin containing silver sulfadiazine for wound healing and showed the controlled release of SSD over h and expected to diminish microbial load in the wound area. " novel SSD-loaded bilayer chitosan membrane was prepared with sustained release of silver which inhibits the growth of P. aeruginosa and S. aureus [116].…”

Section: Silver Dressings In Wound Healingmentioning

confidence: 99%

Antimicrobial Dressings for Improving Wound Healing

Sarheed¹,

Ahmed²,

Shouqair³

et al. 2016

Wound Healing - New Insights Into Ancient Challenges

Self Cite

View full text Add to dashboard Cite

Wound healing occurs by a series of interrelated molecular events which work together to restore tissue integrity and cellular function. These physiological events occur smoothly in normal healthy individual and/or under normal conditions. However, in certain cases, these molecular events are retarded resulting in hard-to-heal or chronic wounds arising from several factors such as poor venous return, underlying physiological or metabolic conditions such as diabetes as well as external factors such as poor nutrition. In most cases, such wounds are infected and infection also presents as another complicating phenomenon which triggers inlammatory reactions, therefore delaying wound healing. There has therefore been recent interests and signiicant eforts in preventing and actively treating wound infections by directly targeting infection causative agents through direct application of antimicrobial agents either alone or loaded into dressings (medicated). These have the advantage of overcoming challenges such as poor circulation in diabetic and leg ulcers when administered systemically and also require lower amounts to be applied compared to that required via oral or iv administration. This chapter will review and evaluate various antimicrobial agents used to target infected wounds, the means of delivery, and current state of the art, including commercially available dressings. Data sources will include mainly peer-reviewed literature, clinical trials and reports, patents as well as government reports where available.

show abstract

Composite alginate and gelatin based bio-polymeric wafers containing silver sulfadiazine for wound healing

Cited by 113 publications

References 31 publications

Composite HPMC and sodium alginate based buccal formulations for nicotine replacement therapy

Composite HPMC and sodium alginate based buccal formulations for nicotine replacement therapy

Evaluation of in vitro wound adhesion characteristics of composite film and wafer based dressings using texture analysis and FTIR spectroscopy: a chemometrics factor analysis approach

Antimicrobial Dressings for Improving Wound Healing

Contact Info

Product

Resources

About